NASDAQ: COCHEnvoy Medical Inc Stock
$2.98-0.33 (-9.97%)
Updated Oct 7, 2024
COCH Price
$2.98
Fair Value Price
$0.10
Market Cap
$58.41M
52 Week Low
$0.75
52 Week High
$11.46
P/E
-7.84x
P/B
-4.72x
P/S
153.17x
PEG
N/A
Dividend Yield
N/A
Revenue
$302.00k
Earnings
-$13.74M
Gross Margin
-171.9%
Operating Margin
-4,493.38%
Profit Margin
-5,001%
Debt to Equity
-1.54
Operating Cash Flow
-$21M
Beta
0
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
COCH Overview
Anzu Special Acquisition Corp I is a "blank check" company formed to effect mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or related combinations with one or more businesses. Anzu targets businesses in the field of industrial applications. The company was incorporated in 2020 and is based in Tampa, FL.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how COCH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
COCH ($2.98) is overvalued by 2,854.61% relative to our estimate of its Fair Value price of $0.10 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
COCH ($2.98) is not significantly undervalued (2,854.61%) relative to our estimate of its Fair Value price of $0.10 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
COCH is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more COCH due diligence checks available for Premium users.
Be the first to know about important COCH news, forecast changes, insider trades & much more!
COCH News
Valuation
COCH fair value
Fair Value of COCH stock based on Discounted Cash Flow (DCF)
Price
$2.98
Fair Value
$0.10
Overvalued by
2,854.61%
COCH ($2.98) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
COCH ($2.98) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
COCH is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
COCH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-7.84x
Industry
40.54x
Market
26.63x
COCH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-4.72x
Industry
3.98x
COCH's financial health
Profit margin
Revenue
$68.0k
Net Income
-$3.9M
Profit Margin
-7,811.8%
COCH's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
COCH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$6.7M
Liabilities
$19.1M
Debt to equity
-1.54
COCH's short-term liabilities ($8.06M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
COCH's long-term liabilities ($11.07M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
COCH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
COCH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$4.9M
Investing
-$790.0k
Financing
$2.5M
COCH's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
COCH vs Medical Device Stocks
Envoy Medical Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.